PharmiWeb.com - Global Pharma News & Resources
13-Jun-2023

Heart Beat Irregularity Detection Device Market is expected to reach US$ 20.7 Million expand from 2023 to 2033 at a CAGR of 4.5%

It is expected that the Heart Beat Irregularity Detection Device Market would expand at a 4.5% CAGR to reach a market value of US$ 20.7 million by the end of 2033, up from US$ 12.8 million in 2022. The market for devices that detect irregular heartbeats is expected to grow as a result of the need for early diagnosis of cardiac arrhythmia in order to provide the best care for heart patients.

The COVID 19 pandemic in 2020 had a somewhat positive impact on the uptake of heartbeat irregularity detecting technology. The decline of COVID-19 cases and the ongoing provision of all healthcare services have had an influence on the market for products that detect irregular heartbeats. Several healthcare businesses are collaborating to increase the manufacturing capacity of heart beat irregularity detection device in order to give medical assistance while maintaining tabs on patients’ development.

As a result of the decreased number of people infected with COVID-19, the heart beat irregularity detection device market is expected to increase significantly in the near future.

Request a report sample to gain comprehensive insights at @
https://www.futuremarketinsights.com/reports/sample/rep-gb-14396

The heart beat irregularity detection device market’s growth is likely to be aided by the development of technologically improved monitoring equipment, such as wireless monitors, that give the benefit of early detection. Due to expanding life expectancy and ongoing developments that have expanded their capabilities and reach, the usage of cardiac rhythm monitoring (CRM) devices has increased dramatically in recent years.

Recent advancements in CRM devices are having a beneficial influence on the rate of product acceptance in developed countries, which will help the sector grow even more. The Holter monitor category is expected to lead in terms of device. The Holter monitor segment’s expansion is attributed to an increase in illness prevalence as a result of increased intake of unhealthy foods and a hurried lifestyle, both of which has an impact on heart health and lead to cardiac blockages and arrests.

During the analysis period, the tachycardia monitoring devices sector is predicted to increase at a 6.8% CAGR based on application. Atrial tachycardia and ventricular tachycardia are two types of tachycardia. In the next years, the use of technologically improved products for illness monitoring is likely to drive up demand for heart beat irregularity detection devices.

In 2021, atrial tachycardia accounted for the bulk of the heart beat irregularity detection devices market, and it is predicted to continue to increase in the near future. The hospitals and clinics segment led the heart beat irregularity detection devices market revenue share by end-use and is expected to increase significantly during the projected period. The rising global prevalence of heart beat irregularity, along with an ageing population, is likely to push hospital admission rates for treatment.

Ask an Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-14396

The heart beat irregularity detection devices market in North America has a large revenue share. The regional heart beat irregularity detection devices market will develop as the prevalence of heart beat irregularity disorders rises, and as people become more aware of modern monitoring procedures. The presence of major heart beat irregularity detection devices market players involved in advanced device commercialization will also help to expand regional markets.

Furthermore, the regional heart beat irregularity detection devices market demand is expected to be boosted by improved healthcare infrastructure, which would lead to an increased usage of technologically sophisticated heart beat irregularity detection devices.

Key Takeaways:

  • The Holter monitor segment of the heart beat irregularity detection devices market was worth more than USD 2.8 billion in 2021, and it is predicted to expand significantly during the forecast period.
  • During the analysis period, the tachycardia monitoring devices sector is expected to increase at a 6.8% CAGR based on application.
  • By the end of the year, the heart beat irregularity detection devices market for resting ECG devices is expected to be worth more than US$ 2.8 billion, with a CAGR of 4.6% during the projection period.
  • The largest region, North America, has a high heart beat irregularity detection devices market attractiveness rating. By the end of the projected period, the heart beat irregularity detection devices market in this area is expected to be worth US$ 2,900 Mn.
  • During the projection period, the mobile heart beat irregularity detection devices market sector is expected to increase at a substantial rate, with a CAGR of 8.4%.
  • With a 5.8% CAGR, the ventricular fibrillation segment is expected to achieve a heart beat irregularity detection devices market worth over US$ 2,500 Mn.
  • During the projection period in heart beat irregularity detection devices market, the hospitals segment is expected to develop at a high CAGR of 6.9%.

Request Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-14396

Competitive Landscape:

  • Philips agreed to buy Cardiology, a medical technology startup focusing on combining cloud technology and artificial intelligence to enhance heart diagnostics, in November 2021. (AI). This purchase expands the company’s heart beat irregularity detection devices product line, providing revenue growth potential in the market.
  • The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) gave AliveCor permission to launch KardiaMobile in Mexico in February 2020. The business has teamed up with Inpharamo to roll out the medical-grade ECG across the United States. As a result, the firm has been able to extend its global reach as well as its client base.

Key Companies Profiled:

  • Alive Cor
  • Applied Cardiac Systems
  • Biotronik
  • Biotricity
  • GE Healthcare
  • iRhythm Technologies
  • Koninklijke Philips N.V.
  • Medtronic plc.
  • Nihon Kohden Corporation
  • St. Jude Medical (Abbott Laboratories)
  • Welch Allyn (Hillrom Services, Inc.)
  • NUUBO Smart Solutions Technologies, SL
  • Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
  • Fukuda Denshi Co., Ltd.
  • Schiller AG
  • Mortara Instrument Inc.
  • BPL Medical Technologies
  • Lepu Medical Technology(Beijing) Co., Ltd

Key Segments Covered in Heart Beat Irregularity Detection Device Industry Research

Devices:

  • Holter Monitor
  • Event Recorder
  • Mobile Cardiac Telemetry
  • Implantable Cardiac Monitor
  • Electrocardiogram
  • Others

Use promo code >> FMITODAY to get flat 20% discount

Applications:

  • Tachycardia
    • Atrial Tachycardia
    • Ventricular Tachycardia
  • Bradycardia
  • Premature Contraction
  • Others

End-User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Editor Details

Last Updated: 13-Jun-2023